經(jīng)皮椎體成形術(shù)后MRI影像與臨床轉(zhuǎn)歸關(guān)系的研究
[Abstract]:Objective: to observe the magnetic resonance imaging (MRI) features of vertebra follow-up after percutaneous vertebroplasty (PVP) and to analyze its correlation with clinical efficacy. Methods: the clinical data of 198 patients underwent vertebroplasty in our hospital from January to June 2015.108 patients (152 treated vertebrae) with complete data were analyzed. The amount of bone cement injected into the vertebral body, X-ray imaging (vertebral height) before and 1 day after operation, MRI imaging results (vertebral height, bone marrow edema) before operation, 3 months after operation, and before operation, 1 day after operation, 3 months after operation. Visual analogue score (VAS),) of postoperative pain was collected and analyzed to observe the clinical manifestations of the patients. Results: VAS was 6.7 鹵1.4 and 2.1 鹵0.7 before operation and 1 day after operation, respectively (P0.05). VAS was 1.7 鹵0.8 and 1.2 鹵0.6 in 3 months and 6 months after operation, respectively. The postoperative vertebral body height increased by 2.4 鹵1.8 mm compared with that before operation, and the loss of postoperative vertebral body height was 0.8 鹵0.5 mm during 6 months follow-up. There was no correlation between the patient's statistical data and the amount of cement injected into the vertebral body after PVP. Among them, 28 (18%) had high loss of vertebral body after operation. 62% of the patients had preoperative MRI imaging and 33% of the follow-up MRI images showed moderate or severe bone marrow edema. 21% of the vertebrae showed moderate or severe bone marrow edema. New areas of bone marrow edema. 22% of vertebrae showed moderate or severe bone marrow edema on MRI imaging 6 months after operation. Conclusion: PVP is effective in the treatment of osteoporotic compression fracture of vertebral body (OVCF). Progressive and persistent bone marrow edema and loss of vertebral body height are common after PVP and should not be regarded as sufficient evidence of postoperative abnormality of vertebral body.
【學(xué)位授予單位】:新疆醫(yī)科大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R687.3
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 張智海;劉忠厚;石少輝;李艷寧;;中國(guó)大陸地區(qū)以-2.5SD為診斷的骨質(zhì)疏松癥發(fā)病率文獻(xiàn)回顧性研究[J];中國(guó)骨質(zhì)疏松雜志;2015年01期
2 祁曉平;黎介壽;;維生素D作為開(kāi)環(huán)甾體激素的研究進(jìn)展[J];醫(yī)學(xué)研究生學(xué)報(bào);2013年07期
3 顧翔;李佳錄;于愛(ài)紅;白榮杰;程曉光;;骨質(zhì)疏松椎體骨折與相關(guān)椎體骨疾患的影像鑒別診斷[J];中國(guó)骨質(zhì)疏松雜志;2012年11期
4 曹奇;唐曉軍;楊鐵軍;陳亮元;唐國(guó)軍;陳小明;顏學(xué)亮;;經(jīng)皮椎體成形術(shù)治療Kümmell’s病后發(fā)生鄰近椎體骨折的原因分析[J];中國(guó)骨質(zhì)疏松雜志;2012年09期
5 王桂華;趙建寧;;骨質(zhì)量的影響因素及其檢測(cè)方法[J];醫(yī)學(xué)研究生學(xué)報(bào);2011年10期
6 俞志興;莫文;馬俊明;葉潔;萬(wàn)宏波;;111例PVP/PKP術(shù)治療胸腰椎老年骨質(zhì)疏松性骨折的回顧性分析[J];中國(guó)骨質(zhì)疏松雜志;2011年09期
7 陳陽(yáng);馬劍雄;馬信龍;;老年性骨質(zhì)疏松骨折研究進(jìn)展[J];中國(guó)骨質(zhì)疏松雜志;2011年09期
8 趙宇馳;孫常太;;骨質(zhì)疏松性椎體壓縮骨折的診斷[J];中國(guó)脊柱脊髓雜志;2010年03期
9 夏維波;;骨質(zhì)疏松癥的防治[J];中國(guó)全科醫(yī)學(xué);2010年02期
10 郭躍春;;脊椎骨質(zhì)疏松性骨折的影像學(xué)診斷[J];醫(yī)學(xué)理論與實(shí)踐;2009年08期
,本文編號(hào):2298719
本文鏈接:http://sikaile.net/yixuelunwen/waikelunwen/2298719.html